Skip to main content
SpringerLink
Log in

Prognostic Factors

  • Chapter
  • First Online:
Book cover Surgical Treatment of Hilar and Intrahepatic Cholangiocarcinoma

Part of the book series: Updates in Surgery ((UPDATESSURG))

  • 790 Accesses

Abstract

Radical surgery is the only therapeutic option that can ensure a long-term survival; until now many aspects of this disease have not been well-known, such as pathogenesis, and clinical and histopathologic factors that determine survival. In this chapter we will analyze the main prognostic factors that influence survival: macroscopic aspect, local extent, lymph-node involvement and distant metastases. Histological characteristics and molecular factors related to prognosis will also be analysed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hoang MP, Murakata LA, Katabi N et al. (2002) Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases. Mod Pathol 15(12):1251–1258

    Article  Google Scholar 

  2. Albores-Saavedra J, Murakata L, Krueger JE, Henson DE (2000) Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts. Cancer 89(3):508–515

    Article  CAS  Google Scholar 

  3. Sakamoto E, Nimura Y, Hayakawa N et al (1998) The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg 227(3):405–411

    Article  CAS  Google Scholar 

  4. Jarnagin WR, Bowne W, Klimstra DS et al (2005) Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 241(5):703–712; discussion 712–714

    Article  Google Scholar 

  5. Dinant S, Gerhards MF, Rauws EA et al (2006) Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumour). Ann Surg Oncol 13(6):872–80

    Article  Google Scholar 

  6. Kondo S, Hirano S, Ambo Y et al (2004) Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg 240(1):95–101

    Article  Google Scholar 

  7. Neuhaus P, Jonas S, Bechstein WO et al (1999) Extended resections for hilar cholangiocarcinoma. Ann Surg 230(6):808–818; discussion 819

    Article  CAS  Google Scholar 

  8. Bhuiya MR, Nimura Y, Kamiya J et al (1992) Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg 215(4):344–349

    Article  CAS  Google Scholar 

  9. Ebata T, Nagino M, Kamiya J et al (2003) Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 238(5):720–727

    Article  Google Scholar 

  10. Liu XF, Zhang H, Zhu SG et al (2006) Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma. World J Gastroenterol 12(29):4706–4709

    Article  CAS  Google Scholar 

  11. Jarnagin WR, Klimstra DS, Hezel M et al (2006) Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. J Clin Oncol 24(7):1152–1160

    Article  CAS  Google Scholar 

  12. Zervos EE, Osborne D, Goldin SB et al (2005) Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach. Am J Surg 190(5):810–815

    Article  Google Scholar 

  13. Itoi T, Shinohara Y, Takeda K et al (2000) Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers. Gastrointest Endocs 52(3)380–386

    Article  CAS  Google Scholar 

  14. Abdalla EK, Vauthey JN (2001) Biliary tract cancer. Curr Opin Gastroenterol 17(5):450–457

    Article  CAS  Google Scholar 

  15. Rajala RV, Radhi JM, Kakkar R et al (2000) Increased expression of N-myristoyltransferase in gallbladder carcinomas. Cancer 88(9):1992–1999

    Article  CAS  Google Scholar 

  16. Cormier JN, Vauthey JN (2000) Biliary tract cancer. Curr Opin Gastroenterol 16(5):437–443

    Article  CAS  Google Scholar 

  17. Rashid A, Ueki T, Gao YT et al (2002) K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China. Clin Cancer Res 8(10):3156–3163

    CAS  PubMed  Google Scholar 

  18. Hong SM, Cho H, Moskaluk CA, Yu E (2007) Measurement of the invasion depth of extrahepatic bile duct carcinoma: an alternative method overcoming the current T classification problems of the AJCC staging system. Am J Surg Pathol 31(2):199–206

    Article  CAS  Google Scholar 

  19. Tabata M, Kawarada Y, Yokoi H et al (2000) Surgical treatment for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 7(2):148–154

    Article  CAS  Google Scholar 

  20. Cha JM, Kim MH, Lee SK et al (2006) Clinicopathological review of 61 patients with early bile duct cancer. Clin Oncol (R Coll Radiol) 18(9):669–677

    Article  CAS  Google Scholar 

  21. Mizumoto R, Ogura Y, Kusuda T (1993) Definition and diagnosis of early cancer of the biliary tract. Hepatogastroenterology 40(1):69–77

    CAS  PubMed  Google Scholar 

  22. Kurosaki I, Tsukada K, Watanabe H, Hatakeyama K (1998) Prognostic determinants in extrahepatic bile duct cancer. Hepatogastroenterology 45(22):905–909

    CAS  PubMed  Google Scholar 

  23. Bhuiya MR, Nimura Y, Kamiya J et al (1993) Clinicopathologic factors influencing survival of patients with bile duct carcinoma: multivariate statistical analysis. World J Surg 17(5):653–657

    Article  CAS  Google Scholar 

  24. Hong SM, Kim MJ, Pi DY et al (2005) Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumour classification problems in 222 patients. Cancer 104(4):802–810

    Article  Google Scholar 

  25. Nishio H, Nagino M, Oda K et al (2005) TNM classification for perihilar cholangiocarcinoma: comparison between 5th and 6th editions of the AJCC/UICC staging system. Langenbecks Arch Surg 390(4):319–327

    Article  Google Scholar 

  26. Kitagawa Y, Nagino M, Kamiya J et al (2001) Lymph-node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg 233(3):385–392

    Article  CAS  Google Scholar 

  27. Nakeeb A, Pitt HA, Sohn TA et al (1996) Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumours. Ann Surg 224(4):463–473; discussion 473–475

    Article  CAS  Google Scholar 

  28. Sugiura Y, Nakamura S, Iida S et al (1994) Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery 115(4):445–451

    CAS  PubMed  Google Scholar 

  29. Iwatsuki S, Todo S, Marsh JW et al (1998) Treatment of hilar cholangiocarcinoma (Klatskin tumours) with hepatic resection or transplantation. J Am Coll Surg 187(4):358–364

    Article  CAS  Google Scholar 

  30. Ogura Y, Kawarada Y (1998) Surgical strategies for carcinoma of the hepatic duct confluence. Br J Surg 85(1):20–24

    Article  CAS  Google Scholar 

  31. Miyazaki M, Ito H, Nakagawa K et al (1999) Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg 189(6):575–583

    Article  CAS  Google Scholar 

  32. Kosuge T, Yamamoto J, Shimada K et al (1999) Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 230(5):663–671

    Article  CAS  Google Scholar 

  33. Miyazaki M, Kato A, Ito H et al (2007) Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 141(5):581–588

    Article  Google Scholar 

  34. Hemming AW, Reed AI, Fujita S et al (2005) Surgical management of hilar cholangiocarcinoma. Ann Surg 241(5):693–699; discussion 699–702

    Article  Google Scholar 

  35. Launois B, Terblanche J, Lakehal M et al (1999) Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg 230(2):266–275

    Article  CAS  Google Scholar 

  36. Nagakawa T, Kayahara M, Ikeda S et al 0 Bilary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan. J Hepatobiliary Pancreat Surg 9(5):569–575

    Article  Google Scholar 

  37. Lai EC, Lau WY (2005) Aggressive surgical resection for hilar cholangiocarcinoma. ANZ J Surg 75(11):981–985

    Article  Google Scholar 

  38. Miyazaki M, Ito H, Nakagawa K et al (1998) Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery 123(2):131–136

    Article  CAS  Google Scholar 

  39. Gerhards MF, van Gulik TM, de Wit LT et al (2000) Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma—a single center experience. Surgery 127(4):395–404

    Article  CAS  Google Scholar 

  40. Schwarz RE, Smith DD (2007) Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. population data. J Gastrointest Surg 11(2):158–165

    Article  Google Scholar 

  41. Tojima Y, Nagino M, Ebata T et al (2003) Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg 237(2):201–207

    PubMed  PubMed Central  Google Scholar 

  42. Taniguchi K, Tabata M, Iida T et al (2006) Significance of lymph node micrometastasis in pN0 hilar bile duct carcinoma. Eur J Surg Oncol 32(2):208–212

    Article  CAS  Google Scholar 

  43. Jarnagin WR, Shoup M (2004) Surgical management of cholangiocarcinoma. Semin Liver Dis 24(2):189–199

    Article  Google Scholar 

  44. Ramacciato G, Corigliano N, Mercantini P et al (2006) [Prognostic factors after surgical resection for hilar cholangiocarcinoma] Ann Chir 131(6–7):379–85, French

    Article  CAS  Google Scholar 

  45. Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumours, 6th edn. Wiley, New York

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. General Surgery A, Department of Surgery and Gastroenterology, University Hospital G.B. Rossi, Verona, Italy

    Alfredo Guglielmi, Andrea Ruzzenente & Calogero Iacono

Authors
  1. Alfredo Guglielmi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea Ruzzenente
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Calogero Iacono
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer

About this chapter

Cite this chapter

Guglielmi, A., Ruzzenente, A., Iacono, C. (2008). Prognostic Factors. In: Surgical Treatment of Hilar and Intrahepatic Cholangiocarcinoma. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-0729-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-0729-1_8

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0728-4

  • Online ISBN: 978-88-470-0729-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation